BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7519219)

  • 1. Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr mice.
    Shirai A; Aoki I; Otani M; Mond JJ; Klinman DM
    J Immunol; 1994 Aug; 153(4):1889-94. PubMed ID: 7519219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice.
    Klinman DM; Eisenberg RA; Steinberg AD
    J Immunol; 1990 Jan; 144(2):506-11. PubMed ID: 2295800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM
    J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes.
    Rubio CF; Kench J; Russell DM; Yawger R; Nemazee D
    J Immunol; 1996 Jul; 157(1):65-71. PubMed ID: 8683157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
    Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
    J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VH gene analysis of spontaneously activated B cells in adult MRL-lpr/lpr mice. J558 bias is not limited to classic lupus autoantibodies.
    Foster MH; MacDonald M; Barrett KJ; Madaio MP
    J Immunol; 1991 Sep; 147(5):1504-11. PubMed ID: 1908876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 contributes to high level IgG production in the murine MRL/lpr lupus model.
    Singh AK; Lebedeva TV
    Immunol Invest; 1994 Aug; 23(4-5):281-92. PubMed ID: 7959962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro role of IL-1 in heightened IgG, anti-DNA, and nephritogenic idiotype production by B cells derived from the murine MRL/lpr lupus model.
    Singh AK; Mao C; Lebedeva TV
    Clin Immunol Immunopathol; 1994 Sep; 72(3):410-5. PubMed ID: 8062453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency.
    Cohen PL; Shores EW; Rapoport R; Caster S; Eisenberg RA; Pisetsky DS
    Cell Immunol; 1985 Dec; 96(2):448-54. PubMed ID: 3879807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal behavior of gamma-committed B lymphocytes probed by a lymphocyte blastogenesis inhibitory factor in autoimmune MRL mice.
    Sugimura K; Wada Y; Kimura T; Ohno T; Kobayashi S; Azuma I
    Eur J Immunol; 1990 Sep; 20(9):1899-904. PubMed ID: 2209696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.
    Ward FJ; Knies JE; Cunningham C; Harris WJ; Staines NA
    Immunology; 1997 Nov; 92(3):354-61. PubMed ID: 9486108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG.
    PeƧanha LM; Yamaguchi H; Lees A; Noelle RJ; Mond JJ; Snapper CM
    J Immunol; 1993 Mar; 150(6):2160-8. PubMed ID: 7680684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-nRNP anti-nuclear antibody-secreting cells are represented in the B-lymphocyte repertoire of normal and MRL/MP-lpr/lpr lupus mice.
    Brennan FM; Andrew EM; Williams DG; Maini RN
    Immunology; 1988 Feb; 63(2):213-7. PubMed ID: 3258271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of IgG and IgM secreting B cells in normal and autoimmune mice.
    Klinman DM
    J Autoimmun; 1994 Feb; 7(1):1-11. PubMed ID: 8198696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.